1,673 material Form 8-K filings that 1,260 companies we cover made with the SEC in February 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Celanese reported fourth-quarter and full-year 2025 results on February 17, 2026. Full-year net sales fell 7% to $9.5 billion, and adjusted EPS was $3.98 versus $8.18 in 2024, while the full-year U.S. GAAP diluted loss per share from continuing operations narrowed to $10.44 from $14.04. The company also guided first-quarter 2026 adjusted EPS to $0.70 to $0.85 and targets 2026 free cash flow of $650 million to $750 million.
Q4 2025 net sales were $2.2 billion, down 9% from the prior quarter and slightly below $2.358 billion in Q4 2024; Q4 adjusted EPS was $0.67 versus $1.33 a year earlier.
Full-year 2025 free cash flow was $773 million, up from $498 million in 2024, and operating cash flow was $1.1 billion.
Full-year 2025 results include Certain Items totaling $1.6 billion, primarily a goodwill and trade name impairment, which drove the U.S. GAAP loss.
First-quarter 2026 adjusted EPS guidance is $0.70 to $0.85, and the company targets 2026 free cash flow of $650 million to $750 million.
The Andersons reported fourth quarter 2025 net income attributable to the company of $67 million, or $1.97 per diluted share, up from $45 million, or $1.31, a year earlier. Full year net income fell to $96 million, or $2.79 per diluted share, from $114 million, or $3.32, and quarterly sales declined to $2.5 billion from $3.1 billion, so shareholders see mixed results.
Q4 2025 adjusted net income was $70 million, or $2.04 per diluted share, versus $1.36 in Q4 2024
Q4 2025 sales and merchandising revenues were $2.5 billion, down from $3.1 billion a year earlier
Renewables Q4 pretax income was $54 million, up from $17 million attributable to the company in Q4 2024
Full year adjusted EBITDA was $337 million in 2025, compared with $363 million in 2024
Pitney Bowes reported fourth-quarter 2025 revenue of $478 million, down 7% from $516 million a year earlier, while adjusted EPS rose 40% to $0.45 and GAAP EPS swung to $0.17 from a loss of $0.21. The company also issued 2026 guidance with revenue of $1,760 million to $1,860 million, below 2025 revenue of $1,893 million, and adjusted EPS of $1.40 to $1.60.
Q4 2025 revenue was $478 million versus $516 million in Q4 2024, a decline of 7%; full-year revenue was $1,893 million versus $2,027 million.
Q4 2025 GAAP EPS was $0.17 versus a loss of $0.21; adjusted EPS was $0.45 versus $0.32. Full-year 2025 GAAP EPS was $0.84 and adjusted EPS was $1.35.
2026 guidance: revenue $1,760 million to $1,860 million, adjusted EBIT $410 million to $460 million, adjusted EPS $1.40 to $1.60, and free cash flow $340 million to $370 million.
In Q4 2025 the company repurchased 12.6 million shares for $127 million, and reduced principal debt by $114 million.
Element Solutions reported fourth quarter and full year 2025 results on February 17, 2026. Net sales rose 8% in the quarter and 4% for the year, and adjusted EBITDA grew 5% and 2%, but GAAP net income fell 89% in the quarter and 22% for the year. The company also introduced 2026 adjusted EBITDA guidance of $650 million to $670 million, which it says includes the Micromax and EFC acquisitions.
Q4 2025 net sales were $676 million, up 8%; organic net sales rose 10%.
Q4 2025 reported net income was $6 million, down 89% from $55 million; GAAP diluted EPS was $0.03 versus $0.23.
Full year 2025 net sales were $2.55 billion and adjusted EBITDA was $548 million; reported net income was $191 million, down 22%.
2026 guidance: full year adjusted EBITDA of $650 million to $670 million and first quarter 2026 adjusted EBITDA of $140 million to $155 million.
La-Z-Boy reported fiscal third-quarter results for the period ended January 24, 2026, with sales up 4% to $542 million. GAAP diluted earnings per share fell to $0.52 from $0.68, and GAAP operating margin declined to 5.5% from 6.7%, so higher sales did not carry through to profit. The company expects fourth-quarter sales of $560 million to $580 million and an adjusted operating margin of 7.5% to 9.0%, and declared a quarterly dividend of $0.242 per share.
Quarter sales of $542 million, up 4% from the prior-year quarter; retail written sales up 11% and wholesale sales up 1%
GAAP diluted EPS of $0.52 versus $0.68 a year earlier; adjusted diluted EPS of $0.61 versus $0.68
Fourth-quarter outlook: sales of $560 million to $580 million and adjusted operating margin of 7.5% to 9.0%
Quarterly dividend of $0.242 per share declared February 17, 2026, payable March 13, 2026 to holders of record March 3, 2026
Centerspace reported full-year 2025 net income of $1.02 per diluted share, up from a net loss of $1.27 in 2024, and Core FFO of $4.93 per share, up from $4.88. For 2026 it guided to a net loss of $(0.49) to $(0.19) per diluted share and Core FFO of $4.81 to $5.05, while its strategic review of alternatives continues with no set timetable.
Q4 2025 net loss was $1.10 per diluted share, versus a $0.31 loss in Q4 2024; Q4 included a $14.5 million impairment of real estate investments.
Full-year 2025 revenue was $273.7 million, up 4.9%; same-store NOI grew 3.5%.
2026 guidance: net income (loss) per diluted share of $(0.49) to $(0.19); Core FFO per diluted share of $4.81 to $5.05, versus $4.93 in 2025.
Quarterly distribution of $0.77 per share, payable April 14, 2026, to holders of record on March 30, 2026.
JBG SMITH reported full-year 2025 results in a Form 8-K. The net loss narrowed to $139.1 million from $143.5 million, but full-year Core FFO fell to $38.9 million from $73.9 million. The filing gives no earnings guidance, and the company said it expects leverage to moderate as newly built multifamily assets lease up.
Full-year 2025 net loss was $139.1 million ($2.09 per diluted share), compared with $143.5 million ($1.65 per diluted share) in 2024.
Full-year 2025 Core FFO was $38.9 million ($0.58 per diluted share), compared with $73.9 million ($0.83 per diluted share) in 2024.
Fourth-quarter 2025 Core FFO was $9.9 million ($0.17 per diluted share), up from $11.6 million ($0.14) a year earlier, while the fourth-quarter net loss was $45.5 million ($0.78 per share).
Same Store NOI at the company's share decreased 4.2% quarter over quarter to $53.6 million in the fourth quarter.
Devon Energy reported fourth-quarter 2025 net earnings of $562 million, or $0.90 per diluted share, down from $693 million in the third quarter and $653 million a year earlier. Production averaged 851,000 Boe per day, above the top end of guidance, and the company is pursuing an all-stock merger with Coterra Energy expected to close in the second quarter of 2026, with a planned 31 percent dividend increase and a new buyback of more than $5 billion after closing.
Q4 2025 net earnings were $562 million ($0.90 per diluted share); core earnings were $510 million ($0.82 per diluted share).
Q4 2025 production averaged 851,000 Boe per day, exceeding the top end of guidance; capital investment was $883 million, 4 percent below guidance.
Merger with Coterra Energy announced Feb. 2, 2026 is expected to close in Q2 2026; quarterly dividend to rise to $0.315 per share after close.
Share repurchases were suspended with the merger announcement; Q1 2026 production is estimated to be reduced 1 percent by severe winter weather.
Glaukos reported record fourth-quarter 2025 net sales of $143.1 million, up 36% from a year earlier, and full-year net sales of $507.4 million, up 32%. A one-time, non-cash impairment charge of $112.9 million tied to the Photrexa to Epioxa transition pushed the fourth-quarter GAAP net loss to $133.7 million, or $2.32 per diluted share, and the company reaffirmed its 2026 net sales guidance of $600 million to $620 million.
Q4 2025 net sales were $143.1 million, up 36% reported and 34% in constant currency, versus $105.5 million in Q4 2024.
Q4 2025 GAAP net loss was $133.7 million, or ($2.32) per diluted share, versus a net loss of $33.6 million, or ($0.60), in Q4 2024.
Non-GAAP net loss for Q4 2025 was $16.4 million, or ($0.28) per diluted share.
The company reaffirmed 2026 net sales guidance of $600 million to $620 million and ended 2025 with about $282.6 million in cash, short-term investments and restricted cash and no debt.
Caesars Entertainment reported fourth-quarter 2025 GAAP net revenues of $2.9 billion, up from $2.8 billion, but a GAAP net loss of $250 million, compared with net income of $11 million a year earlier. The prior-year period included gains on asset sales of over $350 million. Same-store Adjusted EBITDA rose to $901 million, with Caesars Digital setting a quarterly record, while full-year net loss widened to $502 million and full-year same-store Adjusted EBITDA fell to $3.6 billion.
Q4 GAAP net revenues $2.9 billion vs $2.8 billion; Q4 same-store Adjusted EBITDA $901 million vs $882 million
Q4 net loss attributable to Caesars $250 million vs net income of $11 million, driven mainly by prior-year asset sale gains of over $350 million
Full year net loss $502 million vs $278 million; full year same-store Adjusted EBITDA $3.6 billion vs $3.7 billion
Caesars Digital Q4 Adjusted EBITDA $85 million vs $20 million; company expects lower capex and cash interest in 2026
Rogers reported fourth-quarter 2025 net sales of $201.5 million, up 4.8% from a year earlier, and adjusted earnings of $0.89 per diluted share versus $0.46. For the full year, the company swung to a net loss of $61.8 million, or $(3.40) per diluted share, after $97.1 million of restructuring and impairment charges, compared with net income of $26.1 million in 2024. The company also gave first-quarter 2026 guidance of $193 million to $208 million in net sales and $0.45 to $0.85 in adjusted earnings per diluted share.
Q4 2025 net sales were $201.5 million, up from $192.2 million, and GAAP earnings were $0.26 per diluted share versus a loss of $(0.03) a year earlier
Full-year 2025 net sales were $810.8 million, down from $830.1 million, and net loss was $(61.8) million versus net income of $26.1 million in 2024
Restructuring and impairment charges were $97.1 million for 2025 compared with $24.1 million in 2024
Q1 2026 guidance: net sales $193 million to $208 million, adjusted EBITDA $27 million to $35 million, adjusted EPS $0.45 to $0.85
Goosehead Insurance reported fourth-quarter 2025 revenue up 12% to $105.3 million, while net income fell to $20.8 million from $23.8 million a year earlier. The company also gave 2026 guidance of 10% to 19% organic total revenue growth, expanded its share repurchase authorization by $180.0 million, and added Louis Goldberg to its board, effective February 18, 2026. For shareholders, revenue growth was offset by lower profit, and the buyback expansion and guidance will shape expectations for 2026.
Q4 2025 total revenues were $105.3 million, up 12%; Q4 net income was $20.8 million versus $23.8 million, and diluted EPS was $0.48 versus $0.57.
Full-year 2025 net income was $44.5 million versus $49.1 million in 2024; Adjusted EBITDA rose 14% to $113.6 million.
2026 guidance: total revenues expected to grow organically 10% to 19%, and total written premiums 12% to 20%.
Share repurchase authorization increased by $180.0 million and extended through May 1, 2027; $81.7 million of shares were repurchased in 2025.
Halozyme reported fourth-quarter 2025 total revenue of $451.8 million, up 52% from a year earlier, but a net loss of $141.6 million, which included $284.9 million of acquired in-process R&D expense tied to the Surf Bio acquisition. For full-year 2025, total revenue rose 38% to $1.4 billion, and the company reiterated its 2026 guidance for total revenue of $1.710 billion to $1.810 billion and non-GAAP diluted EPS of $7.75 to $8.25.
Q4 2025 total revenue was $451.8 million versus $298.0 million in Q4 2024; royalties were $258.0 million, up 51%.
Q4 2025 net loss was $141.6 million versus net income of $137.0 million a year earlier; GAAP diluted loss was $1.20 per share.
Full-year 2025 total revenue was $1,396.6 million, up 38%, with royalty revenue of $867.8 million, up 52%.
2026 guidance reiterated: total revenue of $1.710 billion to $1.810 billion and non-GAAP diluted EPS of $7.75 to $8.25, last updated January 28, 2026.
RB Global reported fourth-quarter 2025 results with total revenue up 5% to $1.2 billion, while net income and diluted EPS fell 8% and 9%, respectively. The company also gave 2026 guidance for adjusted EBITDA of $1,470 million to $1,530 million and disclosed a $59.6 million arbitration award to its former CEO, which is reflected in its 2025 financial statements.
Q4 2025 total revenue rose 5% year over year to $1.2 billion; net income fell 8% to $109.4 million.
Diluted EPS fell 9% to $0.53; diluted adjusted EPS rose 17% to $1.11.
2026 outlook: adjusted EBITDA of $1,470 million to $1,530 million, versus $1,399.7 million in 2025.
On February 16, 2026, an arbitration panel awarded the former CEO $59.6 million; a quarterly dividend of $0.31 per share is payable March 2, 2026.
Itron reported fourth-quarter 2025 revenue of $572 million, down 7% from a year earlier, while GAAP diluted earnings per share rose to $2.21 from $1.26, helped by a tax benefit. For 2026, the company forecast non-GAAP diluted EPS of $5.75 to $6.25, compared with $7.13 for full-year 2025, and revenue of $2.35 billion to $2.45 billion.
Q4 2025 revenue was $572 million, down 7%, driven by portfolio optimization and the timing of project deployments.
Q4 GAAP diluted EPS was $2.21 versus $1.26; non-GAAP diluted EPS was $2.46 versus $1.35.
Full-year 2025 revenue was $2.4 billion, down 3%; full-year non-GAAP diluted EPS was $7.13.
2026 outlook: Q1 revenue $565 million to $575 million; full-year revenue $2.35 billion to $2.45 billion and non-GAAP diluted EPS $5.75 to $6.25.
Kite Realty Group reported fourth-quarter 2025 net income attributable to common shareholders of $180.8 million, or $0.84 per diluted share, up from $21.8 million a year earlier, mainly due to a $183.1 million gain on property sales. Core FFO fell to $112.9 million, or $0.51 per diluted share, from $0.52 a year earlier, and total revenue declined, while the company issued initial 2026 guidance of $2.06 to $2.12 per diluted share for Core FFO.
Q4 2025 net income attributable to common shareholders was $180.8 million, or $0.84 per diluted share, versus $21.8 million, or $0.10, in Q4 2024.
Q4 2025 Core FFO of the Operating Partnership was $112.9 million, or $0.51 per diluted share, versus $0.52 in Q4 2024; total revenue was $204.9 million versus $212.2 million.
2026 guidance: Core FFO of $2.06 to $2.12 per diluted share and net income of $0.36 to $0.42 per diluted share.
Board declared a first quarter 2026 dividend of $0.29 per common share, a 7.4% year-over-year increase, payable on or about April 16, 2026.
Franklin Electric reported fourth quarter 2025 net sales of $506.9 million, up 4%, and diluted EPS of $0.87, up from $0.72. For full year 2025, GAAP diluted EPS fell to $3.22 from $3.86 after a $54.9 million pre-tax pension settlement charge from terminating its US Pension Plan, while adjusted diluted EPS rose 6% to $4.14. The company also guided 2026 sales of $2.17 billion to $2.24 billion and adjusted diluted EPS of $4.40 to $4.60.
Q4 2025 operating income was $51.6 million, up 20% from $43.0 million, with operating margin of 10.2%.
Full year 2025 net sales were $2.1 billion, up 5%, and operating income was $269.0 million, up 10%.
The US Pension Plan termination cut full year 2025 GAAP diluted EPS by an estimated $0.91 per share net of tax, according to the company.
2026 guidance: sales of $2.17 billion to $2.24 billion and adjusted diluted EPS of $4.40 to $4.60.
Genuine Parts reported a fourth-quarter 2025 net loss of $609 million, or $(4.39) per diluted share, compared with net income of $133 million, or $0.96 per share, a year earlier. The loss reflects an $825 million after-tax pension settlement and other non-recurring items, while sales rose 4.1% to $6.0 billion and adjusted diluted EPS fell to $1.55 from $1.61. The company also announced a plan to separate its automotive and industrial businesses into two public companies and issued 2026 guidance.
Q4 2025 sales were $6.0 billion, up 4.1%; net loss was $609 million, including a $741.97 million pre-tax pension settlement charge
Full-year 2026 guidance: diluted EPS of $6.10 to $6.60 and adjusted diluted EPS of $7.50 to $8.00, versus full-year 2025 adjusted diluted EPS of $7.37
Quarterly dividend raised 3.2% to $1.0625 per share, payable April 2, 2026 to holders of record March 6, 2026
Board announced intent to separate Automotive Parts Group and Industrial Parts Group into two independent, publicly traded companies
NeoGenomics reported fourth-quarter and full-year 2025 results on February 17, 2026, with full-year revenue up 10% to $727 million and a full-year net loss of $108 million, up 37% from 2024. The company also issued 2026 guidance calling for revenue of $793 million to $801 million and a net loss of $50 million to $63 million, which matters to shareholders because it sets the company's first public outlook for 2026.
Q4 2025 revenue rose 11% to $190 million; Q4 net loss narrowed 36% to $10 million
Full-year 2025 net loss was $108 million, up from $79 million in 2024, including $27.8 million in impairment charges
2026 guidance: revenue of $793 million to $801 million, net loss of $50 million to $63 million, adjusted EBITDA of $55 million to $57 million
The filing says the RaDaR ST patent litigation was successfully resolved
Vulcan Materials reported fourth-quarter 2025 net earnings attributable to Vulcan of $252 million, down from $294 million a year earlier, while revenue rose to $1.91 billion from $1.85 billion. For full-year 2025, revenue, net earnings and diluted EPS from continuing operations all increased, and the company gave 2026 guidance calling for Adjusted EBITDA of $2.4 billion to $2.6 billion.
Q4 2025 diluted EPS attributable to Vulcan was $1.91, versus $2.23 in Q4 2024; adjusted diluted EPS was $1.70, versus $2.17.
Full-year 2025 total revenues were $7.94 billion, versus $7.42 billion, and diluted EPS from continuing operations was $8.15, versus $6.91.
2026 outlook: net earnings attributable to Vulcan of $1.1 billion to $1.3 billion and Adjusted EBITDA of $2.4 billion to $2.6 billion.
Cash from operating activities was $1.8 billion in 2025, up 29 percent; the company returned $698 million to shareholders through buybacks and dividends.
Knife River reported record fourth-quarter 2025 revenue of $755.1 million, up 15%, and net income of $32.0 million, up 38%. For the full year, revenue rose 9% to $3.15 billion, but net income fell 22% to $157.1 million, and the company issued 2026 guidance of $3.3 billion to $3.5 billion in revenue and $520 million to $560 million in adjusted EBITDA.
Q4 2025 diluted EPS was $0.56, versus $0.41 a year earlier; full-year diluted EPS was $2.76, versus $3.55 in 2024.
Full-year 2025 adjusted EBITDA rose 7% to $496.5 million, while the adjusted EBITDA margin fell to 15.8% from 16.0%.
2026 guidance: revenue of $3.3 billion to $3.5 billion and adjusted EBITDA of $520 million to $560 million, based on normal weather and conditions and excluding potential acquisitions.
The company completed five acquisitions in 2025 and reported year-end backlog of $1.03 billion, versus $745.6 million a year earlier.
DFIN reported fourth-quarter 2025 net sales of $172.5 million, up 10.4%, and Adjusted EBITDA of $45.8 million, up 44.5%, while GAAP net earnings of $6.2 million were roughly flat against $6.3 million a year earlier. For the full year, net sales fell 1.9% to $767.0 million and net earnings fell 64.9% to $32.4 million, reflecting an $82.8 million pension plan settlement charge. The company guided first-quarter 2026 total net sales to $200 million to $210 million.
Q4 2025 net sales were $172.5 million, up 10.4% from $156.3 million in Q4 2024, led by software solutions growth of 11.4%.
Q4 2025 GAAP net earnings were $6.2 million, or $0.23 per diluted share, versus $6.3 million, or $0.21, in Q4 2024.
Full-year 2025 net earnings were $32.4 million versus $92.4 million in 2024, including an $82.8 million pension plan settlement charge.
First-quarter 2026 guidance: total net sales of $200 million to $210 million and Adjusted EBITDA margin of 33% to 35%.
Medtronic reported fiscal third-quarter 2026 revenue of $9.017 billion, up 8.7% as reported and 6.0% organic, but GAAP diluted EPS fell to $0.89 from $1.01 a year earlier and non-GAAP diluted EPS fell to $1.36 from $1.39. The company reiterated its FY26 organic revenue growth of about 5.5% and non-GAAP diluted EPS guidance of $5.62 to $5.66, so shareholders see sales growth alongside lower profit per share in the quarter.
Q3 revenue of $9.017 billion, up 8.7% as reported and 6.0% organic, 50 basis points ahead of Q3 guidance
GAAP diluted EPS of $0.89 vs. $1.01 a year earlier; non-GAAP diluted EPS of $1.36 vs. $1.39
Cardiovascular Portfolio revenue of $3.457 billion, up 13.8%; Cardiac Ablation Solutions revenue up 80%
FY26 guidance reiterated: organic revenue growth of about 5.5% and non-GAAP diluted EPS of $5.62 to $5.66, including a potential tariff impact of about $185 million
CNH Industrial reported fourth-quarter 2025 consolidated revenues up 6% to $5.16 billion, but net income fell 49% to $89 million and diluted EPS fell to $0.07 from $0.14. For full-year 2025, revenues declined 9% to $18.10 billion and net income fell to $505 million from $1,259 million. The company expects global industry retail demand for agricultural equipment to be about 5% lower in 2026 and forecasts 2026 adjusted diluted EPS of $0.35 to $0.45.
Q4 2025 net income was $89 million, versus $176 million in Q4 2024; Q4 included $123 million in non-cash impairment charges tied to the 2021 Raven acquisition and $62 million tied to Monarch Tractor and other minority holdings.
Full-year 2025 consolidated revenues were $18.10 billion, down 9%; full-year diluted EPS was $0.41, versus $0.99 in 2024; adjusted diluted EPS was $0.55, versus $1.05.
2026 outlook: Agriculture net sales down 5% to flat year-over-year; Industrial free cash flow of $150 million to $350 million; adjusted diluted EPS of $0.35 to $0.45.
Full-year 2025 net cash provided by operating activities was $2,538 million, and Industrial free cash flow was $513 million.
Portland General Electric agreed on February 15, 2026 to acquire PacifiCorp's Washington transmission and distribution business and three generation facilities for $1.9 billion in cash, with a Manulife-led group expected to hold a minority stake. The deal depends on several regulatory approvals and can be terminated after August 15, 2027, with $35 million termination fees in certain cases. The same day, the company reported 2025 GAAP earnings of $2.77 per diluted share, down from $3.01 in 2024, and initiated 2026 adjusted EPS guidance of $3.33 to $3.53.
Cash consideration of $1.9 billion at closing, funded in part by up to $1.9 billion in 364-day bridge loans and up to $600 million of equity commitments from Manulife Infrastructure Fund III, L.P. and affiliates
Closing requires Required Regulatory Approvals, including HSR, FERC, WUTC and OPUC; either party may terminate after August 15, 2027
2025 GAAP net income of $306 million, or $2.77 per diluted share, versus $313 million, or $3.01, in 2024; total revenues rose to $3,576 million from $3,440 million
2026 adjusted EPS guidance of $3.33 to $3.53 per diluted share; quarterly dividend of $0.525 per share payable April 15, 2026
Leidos reported fourth-quarter revenue of $4.2 billion, down 4% year over year, while diluted EPS rose 19% to $2.53, which the company attributed to the six-week government shutdown and the prior-year extra work week. For fiscal 2025, revenue grew 3% to $17.2 billion and diluted EPS rose 21% to $11.14, and Leidos issued fiscal 2026 guidance calling for revenue of $17.5 billion to $17.9 billion and non-GAAP diluted EPS of $12.05 to $12.45. The company also agreed to acquire power design firm Entrust for $2.4 billion, expected to close in the first half of fiscal 2026.
Q4 revenue $4.2 billion, down 4%; Q4 net income $335 million, up 19%
FY2025 revenue $17.2 billion, up 3%; FY2025 diluted EPS $11.14, up 21%
FY2026 guidance: revenue $17.5 billion to $17.9 billion; non-GAAP diluted EPS $12.05 to $12.45
Entrust acquisition for $2.4 billion, subject to customary adjustments; expected close in first half of fiscal 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.